- Current languageen
Community Register of medicinal products
List of referrals for human medicinal products
Tazocin and associated names
|Product name:||Tazocin and associated names|
|Also marketed in the EU under the name(s):||Tazobac, Tazocel, Tazocilline, Tazocin, Tazonam|
|Indication:||Tazocin is indicated for the treatment of the following infections|
- Adults and adolescents
Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.
Tazocin may be used in the management of neutropenic patients with fever suspected to be due to a bacterial infection.
- Children 2 to 12 years of age
Tazocin may be used in the management of neutropenic children with fever suspected to be due to a bacterial infection.
|Marketing Authorisation Holder:||Pfizer Limited|
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|23/02/2011||Referral||EMEA/H/A-30/1149||(2011)1196 of 21/02/2011|